Jinchun Wu

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Ischemia Reperfusion Injury

Top Venues

Oxidative medicine and cellular longevity

Genetics research

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Wei Zhang, Zhixing Fan, Fengyuan Wang, Lin Yin, Jinchun Wu, Dengke Li, Siwei Song, Xi Wang, Yanhong Tang, Congxin Huang
Tubeimoside I Ameliorates Doxorubicin-Induced Cardiotoxicity by Upregulating SIRT3. Oxidative medicine and cellular longevity 2023 (2023)
Wei Zhang, Zhixing Fan, Fengyuan Wang, Lin Yin, Jinchun Wu, Dengke Li, Siwei Song, Xi Wang, Yanhong Tang, Congxin Huang
Tubeimoside I Ameliorates Doxorubicin-Induced Cardiotoxicity by Upregulating SIRT3. Oxidative medicine and cellular longevity 2023 (2023)
Rong Chang, Wenqin Zhou, Yi Ye, Xiaofei Zhang, Yanmin Liu, Jinchun Wu
Relationship between CYP2C19 Polymorphism and Clopidogrel Resistance in Patients with Coronary Heart Disease and Ischemic Stroke in China. Genetics research 2022 (2022)
Rong Chang, Jinchun Wu, Xiaofei Zhang, Yi Ye, Wenqin Zhou, Yanmin Liu
Analysis of the Reactivity of Aspirin and Clopidogrel and Its Influencing Factors in Patients with Coronary Heart Disease at High Altitude. Evidence-based complementary and alternative medicine : eCAM 2021 (2021)